Where is Virpax’s corporate headquarters?

Virpax Pharmaceuticals, Inc.
1055 Westlakes Drive, Suite 300, Berwyn, PA 19312

Where is the company incorporated?

Delaware

When did Virpax go public?

February 16, 2021

When does VIRPAX’s fiscal year end?

December 31

What exchange is VIRPAX traded on?

NASDAQ Capital Markets (NCM)

Who is VIRPAX’s transfer agent?

VStock Transfer, LLC
18 Lafayette Place
Woodmere, NY 11598
212-828-8436

Whom do I contact with questions about my stock?

Please contact:
VStock Transfer, LLC
18 Lafayette Place
Woodmere, NY 11598
212-828-8436

How do I transfer stock, change the address on my shareholder account, or replace a lost stock certificate?

Please contact:
VStock Transfer, LLC
18 Lafayette Place
Woodmere, NY 11598
212-828-8436

Who is Virpax’s auditor?

EisnerAmper, LLP

Who is Virpax’s legal counsel?

Blank Rome, LLP

Who is Virpax’s investor relations contact?

Affinity Growth Advisors

Who are Virpax’s major holders, institutional holders, and mutual fund holders?

You may view Virpax’s top holders via the following link: Click Here

BUSINESS INQUIRIES

Virpax Pharmaceuticals, Inc.
1055 Westlakes Drive, Suite 300
Berwyn, PA 19312
610.727.4597
‍info@virpaxpharma.com

INVESTOR INQUIRIES

Betsy Brod
Affinity Growth Advisors
‍betsy.brod@affinitygrowth.com

MEDIA INQUIRIES

Public Relations
Virpax Pharmaceuticals, Inc.
‍pr@virpaxpharma.com